Global Spinal Muscular Atrophy Market and Competitive Landscape - 2018

  • ID: 4630064
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest research Global Spinal Muscular Atrophy Market and Competitive Landscape - 2018, provides comprehensive insights into Spinal Muscular Atrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Spinal Muscular Atrophy market size and drug sales. This research also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

The research is classified into following sections - Spinal Muscular Atrophy overview with definitions, symptoms, etiology, diagnosis, treatment options; Spinal Muscular Atrophy pipeline insights covering late stage clinical trials pipeline; Spinal Muscular Atrophy prevalence trends by countries; Spinal Muscular Atrophy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:
  • Spinal Muscular Atrophy pipeline: Find out the drugs in clinical trials for Spinal Muscular Atrophy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Spinal Muscular Atrophy epidemiology: Find out the prevalence of Spinal Muscular Atrophy by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Spinal Muscular Atrophy products: Identify key products marketed and prescribed for Spinal Muscular Atrophy by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Spinal Muscular Atrophy market size: Find out the market size for Spinal Muscular Atrophy drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Spinal Muscular Atrophy drug sales: Find out the sales of Spinal Muscular Atrophy drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Spinal Muscular Atrophy drugs sales forecast: Sales forecast for Spinal Muscular Atrophy drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Spinal Muscular Atrophy market share analysis: Find out the market shares of Spinal Muscular Atrophy drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research:
  • Evaluate commercial market opportunities for Spinal Muscular Atrophy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Spinal Muscular Atrophy market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Spinal Muscular Atrophy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Spinal Muscular Atrophy: Disease Overview
1.1. Spinal Muscular Atrophy Symptoms
1.2. Spinal Muscular Atrophy Etiology
1.3. Spinal Muscular Atrophy Diagnosis
1.4. Spinal Muscular Atrophy Treatment Options

2. Spinal Muscular Atrophy Pipeline Insights
2.1. Spinal Muscular Atrophy Phase 3 Clinical Trials
2.2. Spinal Muscular Atrophy Phase 2 Clinical Trials
2.3. Spinal Muscular Atrophy Phase 1 Clinical Trials

3. Spinal Muscular Atrophy Epidemiology Analysis

4. US Spinal Muscular Atrophy Market Insights
4.1. Marketed Products for Spinal Muscular Atrophy in US
4.2. US Spinal Muscular Atrophy Market Size & Forecast
4.3. US Spinal Muscular Atrophy Product Sales Forecast
4.4. US Spinal Muscular Atrophy Market Share Analysis

5. Germany Spinal Muscular Atrophy Market Insights
5.1. Marketed Products for Spinal Muscular Atrophy in Germany
5.2. Germany Spinal Muscular Atrophy Market Size & Forecast
5.3. Germany Spinal Muscular Atrophy Product Sales Forecast
5.4. Germany Spinal Muscular Atrophy Market Share Analysis

6. France Spinal Muscular Atrophy Market Insights
6.1. Marketed Products for Spinal Muscular Atrophy in France
6.2. France Spinal Muscular Atrophy Market Size & Forecast
6.3. France Spinal Muscular Atrophy Product Sales Forecast
6.4. France Spinal Muscular Atrophy Market Share Analysis

7. Italy Spinal Muscular Atrophy Market Insights
7.1. Marketed Products for Spinal Muscular Atrophy in Italy
7.2. Italy Spinal Muscular Atrophy Market Size & Forecast
7.3. Italy Spinal Muscular Atrophy Product Sales Forecast
7.4. Italy Spinal Muscular Atrophy Market Share Analysis

8. Spain Spinal Muscular Atrophy Market Insights
8.1. Marketed Products for Spinal Muscular Atrophy in Spain
8.2. Spain Spinal Muscular Atrophy Market Size & Forecast
8.3. Spain Spinal Muscular Atrophy Product Sales Forecast
8.4. Spain Spinal Muscular Atrophy Market Share Analysis

9. UK Spinal Muscular Atrophy Market Insights
9.1. Marketed Products for Spinal Muscular Atrophy in UK
9.2. UK Spinal Muscular Atrophy Market Size & Forecast
9.3. UK Spinal Muscular Atrophy Product Sales Forecast
9.4. UK Spinal Muscular Atrophy Market Share Analysis

10. Europe Spinal Muscular Atrophy Market Insights
10.1. Europe Spinal Muscular Atrophy Market Size & Forecast
10.2. Europe Spinal Muscular Atrophy Product Sales Forecast
10.3. Europe Spinal Muscular Atrophy Market Share Analysis

11. Japan Spinal Muscular Atrophy Market Insights
11.1. Marketed Products for Spinal Muscular Atrophy in Japan
11.2. Japan Spinal Muscular Atrophy Market Size & Forecast
11.3. Japan Spinal Muscular Atrophy Product Sales Forecast
11.4. Japan Spinal Muscular Atrophy Market Share Analysis

12. Global Spinal Muscular Atrophy Market Insights
12.1. Global Spinal Muscular Atrophy Market Size & Forecast
12.2. Global Spinal Muscular Atrophy Product Sales Forecast
12.3. Global Spinal Muscular Atrophy Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Spinal Muscular Atrophy Phase 3 Clinical Trials, Global, 2018
Table 2: Spinal Muscular Atrophy Phase 2 Clinical Trials, Global, 2018
Table 3: Spinal Muscular Atrophy Phase 1 Clinical Trials, Global, 2018
Table 4: Spinal Muscular Atrophy Prevalence by G7 Countries, 2017 - 2023
Table 5: Marketed Products for Spinal Muscular Atrophy in US, 2017
Table 6: US Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 7: US Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 8: US Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 9: Marketed Products for Spinal Muscular Atrophy in Germany, 2017
Table 10: Germany Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 11: Germany Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 12: Germany Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 13: Marketed Products for Spinal Muscular Atrophy in France, 2017
Table 14: France Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 15: France Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 16: France Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 17: Marketed Products for Spinal Muscular Atrophy in Italy, 2017
Table 18: Italy Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 19: Italy Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 20: Italy Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 21: Marketed Products for Spinal Muscular Atrophy in Spain, 2017
Table 22: Spain Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 23: Spain Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 24: Spain Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 25: Marketed Products for Spinal Muscular Atrophy in UK, 2017
Table 26: UK Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 27: UK Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 28: UK Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 29: Europe Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 30: Europe Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 31: Marketed Products for Spinal Muscular Atrophy in Japan, 2017
Table 32: Japan Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 33: Japan Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Table 34: Japan Spinal Muscular Atrophy Market Trends, 2014 - 2023
Table 35: Global Spinal Muscular Atrophy Market Size & Forecast ($mn), 2014 - 2023
Table 36: Global Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023

List of Figures
Figure 1: Spinal Muscular Atrophy Pipeline by Phase (%), Global, 2018
Figure 2: Spinal Muscular Atrophy Prevalence by G7 Countries, 2017 - 2023
Figure 3: US Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 4: US Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 5: US Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 6: US Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 7: Germany Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 8: Germany Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 9: Germany Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 10: Germany Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 11: France Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 12: France Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 13: France Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 14: France Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 15: Italy Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 16: Italy Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 17: Italy Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 18: Italy Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 19: Spain Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 20: Spain Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 21: Spain Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 22: Spain Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 23: UK Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 24: UK Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 25: UK Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 26: UK Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 27: Europe Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 28: Europe Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 29: Europe Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 30: Europe Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 31: Japan Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 32: Japan Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 33: Japan Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 34: Japan Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Figure 35: Global Spinal Muscular Atrophy Market Size ($mn), 2014 - 2023
Figure 36: Global Spinal Muscular Atrophy Product Sales ($mn), 2014 - 2023
Figure 37: Global Spinal Muscular Atrophy Market Share by Products (%), 2017
Figure 38: Global Spinal Muscular Atrophy Market - Future Market Share (%), 2023
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll